Skip to main content

Table 1 Clinical data comparison of patients in CSF and NCF groups

From: Relationship between quantitative epicardial adipose tissue based on coronary computed tomography angiography and coronary slow flow

Variables

CSF group (n = 39)

NCF group (n = 46)

t/χ2/Z

P-value

Cardiovascular risk factors

Age (years)

59.82 ± 9.67

57.54 ± 10.85

−1.01a

0.314

Male, n (%)

28 (71.79)

29 (63.04)

0.73b

0.392

BMI (kg/m2)

25.52 ± 3.49

24.65 ± 3.58

−1.13a

0.261

WBC (×109/L)

5.80 [5.20–7.70]

6.50 [5.65–8.25]

−1.77c

0.078

NEU (×109/L)

3.59 [3.07–4.70]

3.93 [3.19–5.56]

−1.77c

0.077

HCY (umol/L)

10.88 [10.07–13.46]

9.43 [8.06–11.84]

−2.74c

0.006

CHOL (mmol/L)

4.36 ± 1.14

3.78 ± 0.90

−2.66a

0.009

HDL-C (mmol/L)

1.20 ± 0.30

1.14 ± 0.25

−0.93a

0.354

LDL-C (mmol/L)

2.39 ± 0.77

2.03 ± 0.71

−2.26a

0.026

Hypertension, n (%)

23 (58.97)

21 (45.65)

1.50b

0.221

Smoking, n (%)

24 (61.54)

20 (43.48)

2.76b

0.097

CCTA

    

EATV (mL)

128.83 ± 21.59

101.87 ± 18.56

−6.83a

< 0.001

Epicardial FAI (HU)

−84.79 ± 5.96

−83.48 ± 6.53

0.96a

0.342

Echocardiography

LV diameter (mm)

49.04 ± 4.53

47.47 ± 3.14

−1.60a

0.115

LVEF

0.64 ± 0.06

0.63 ± 0.04

2.68a

0.269

E/A

0.84 ± 0.29

0.92 ± 0.33

0.95a

0.345

  1. The data are expressed as n (%) or mean± SD or median [Q1-Q3]
  2. CSF coronary slow flow, NCF normal coronary flow, BMI body mass index, WBC white blood cells, NEU neutrophils, HCY homocysteine, CHOL serum total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, CCTA coronary computed tomography angiography, EATV epicardial adipose tissue volume, FAI fat attenuation index, LV left ventricular, LVEF left ventricular ejection fraction, E/A the ratio of diastolic mitral inflow velocity E peak and A peak
  3. a indicates t-value; b indicates χ2-value; c indicates Z-value